In a groundbreaking development in the world of pharmaceuticals, a highly-anticipated webinar has been announced to delve into the transformative power of Artificial Intelligence and Machine Learning in Particle Analysis for Solid Dosage Formulation and Manufacturing. Scheduled for September 26th, 2023, at 7 a.m. PT, 10 a.m. ET and 7:30 p.m. IST this event promises to be a game-changer for the industry.

Particle analysis assisted by AI/ML in solid dosage formulation and manufacturing involves using artificial intelligence and machine learning to optimize pharmaceutical processes. It helps analyze particle properties, improve drug formulation, enhance quality control, monitor manufacturing processes, predict maintenance needs, ensure regulatory compliance, reduce batch variability, assess risks, and integrate data from various sources. This approach enhances efficiency, quality, and the ability to develop effective solid dosage forms in the pharmaceutical industry.

This webinar marks a significant step forward in the pharmaceutical industry's pursuit of excellence. AI and ML are revolutionizing particle analysis, ultimately

leading to better patient health outcomes,said Sandeep Kulkarni, CEO of ImageProVision.

The webinar sponsored by ImageProVision and presented by American Pharmaceutical Review aims to explore the pivotal role played by particle size and morphology in determining the quality, safety, and efficacy of solid dosage forms. Traditional methods, while informative, often need to provide a comprehensive understanding of particle characteristics.

Insights from Presenters:

1. Nitin Swarnakar, Ph.D.: As the Applications Manager at BASF Pharma Solutions, Nitin Swarnakar brings extensive expertise. He is expected to discuss the role of particle morphology of excipients in drug delivery strategies.

2. Stephen Hammond: Stephen Hammond, a Principal at Steve Hammond Consulting, will discuss the significance of particle analysis in manufacturing and controlling solid dosage forms.

3. Samir Haddouchi: Samir Haddouchi, the Managing Director at SOTAX Pharma Services, is anticipated to discuss particle characterization to troubleshoot failing bioequivalence tests.

4. Sandeep Kulkarni: As the CEO of ImageProVision, Sandeep Kulkarni will discuss how AI/ML can be used to derive predictive analytics of critical quality and process attributes.

Mike Auerbach, Editor-in-Chief of the American Pharmaceutical Review, will moderate the panel discussion, ensuring an engaging and insightful conversation.

This webinar is a must-attend event for professionals in R&D, formulation development, manufacturing, PAT, and QA/QC, providing them with invaluable insights into the future of solid dosage formulation and manufacturing. With particle analysis and AI/ML at the forefront, it promises to be a milestone event that could significantly impact health outcomes through improved drug product quality and safety. Don't miss this opportunity to learn from the industry's leading experts on  

In conclusion, the webinar promises to be an enlightening event that could reshape the future of pharmaceuticals. Industry leaders will convene to share their knowledge and experiences, paving the way for safer and more effective medications. Mark your calendars for September 26th, 2023, as this is a webinar you will want to attend. 

Register Now!